The Viral Hemorrhagic Fever Consortium is a partnership of international research institutions investigating Ebola and Lassa. Our mission is to promote global health and safety by creating new products to diagnose, treat, and significantly reduce the incidence and mortality of viral hemorrhagic fevers.


Latest News & Publications

How do antibodies protect against infection with Ebola virus?

In two papers published in Cell and Cell Host Microbe VHFC investigators describe in detail antibody responses to Ebola virus. By systematic analysis of a large set of more than 170 monoclonal antibodies to Ebola virus, the researchers show which immunological...

T cell responses in patients during the Ebola epidemic

VHFC Scientists conducting the first comprehensive study of key immune system cells - collected from West African Ebola survivors - that kill Ebola infected cells have made a surprising discovery that provides important clues to developing effective vaccines against...